SAVA
Cassava Sciences Inc
NASDAQ: SAVA · HEALTHCARE · BIOTECHNOLOGY
$1.45
+0.69% today
Updated 2026-04-30
Market cap
$142.03M
P/E ratio
—
P/S ratio
2.54x
EPS (TTM)
$-2.22
Dividend yield
—
52W range
$1 – $5
Volume
0.5M
Cassava Sciences Inc (SAVA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $53.92M | $65.98M | $63.73M | $20.56M | $16.81M | $11.48M | $10.89M | $41.12M | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1800.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +22.4% | -3.4% | -67.7% | -18.3% | -31.7% | -5.2% | +277.6% | -100.0% | — | — | — | — | — | — | — | — | +100.0% | — | — |
| Cost of revenue | — | — | — | — | — | — | $7605.00 | $4917.00 | $7306.00 | $9.10M | $9.18M | $7.62M | $2.97M | $1.57M | $3.05M | $534000.00 | $1.30M | $89.42M | $1.13M | $936000.00 |
| Gross profit | $53.92M | $65.98M | $63.73M | $20.56M | $16.81M | $11.48M | $10.89M | $41.12M | $-7306.00 | $-9.10M | $-9.18M | $-7.62M | $-2.97M | $-1.57M | $-3.05M | $-534000.00 | $-1800.00 | $-89.42M | $-1.13M | $-936000.00 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | — | — | — | — | — | — | — | — | 100.0% | — | — | — |
| R&D | $46.80M | $47.73M | $45.82M | $21.06M | $15.75M | $8.30M | $7.61M | $4.92M | $7.31M | $9.10M | $9.18M | $7.62M | $2.97M | $1.57M | $7.25M | $24.81M | $68.03M | $89.42M | $69.64M | $26.59M |
| SG&A | $7.67M | $8.09M | $9.20M | $6.26M | $14.77M | $6.70M | $7.18M | $4.84M | $5.13M | $5.10M | $5.78M | $4.33M | $3.69M | $3.39M | $3.74M | $8.05M | $11.99M | $16.53M | $71.81M | $68.80M |
| Operating income | $-553000.00 | $10.17M | $8.71M | $-6.75M | $-13.70M | $-3.51M | $-3.90M | $31.36M | $-12.43M | $-14.20M | $-14.96M | $-11.95M | $-6.66M | $-4.96M | $-6.45M | $-32.87M | $-80.02M | $-105.96M | $-141.45M | $-95.39M |
| Operating margin | -1.0% | 15.4% | 13.7% | -32.8% | -81.5% | -30.6% | -35.8% | 76.3% | — | — | — | — | — | — | — | — | 4445555.6% | — | — | — |
| EBITDA | $-26.41M | $10.53M | $9.16M | $-6.50M | $-13.70M | $-3.35M | $-3.77M | $31.47M | $-12.42M | $-14.16M | $-14.90M | $-11.88M | $-6.59M | $-4.90M | $-6.77M | $-32.33M | $-78.72M | $-104.43M | $-141.15M | $-94.45M |
| EBITDA margin | -49.0% | 16.0% | 14.4% | -31.6% | -81.5% | -29.2% | -34.7% | 76.5% | — | — | — | — | — | — | — | — | 4373277.8% | — | — | — |
| EBIT | $-553000.00 | $10.17M | $8.71M | $-6.75M | $-13.94M | $-3.51M | $-3.90M | $31.36M | $-12.43M | $-14.20M | $-14.96M | $-11.95M | $-6.66M | $-4.96M | $-6.79M | $-32.87M | $-80.02M | $-105.96M | $-142.28M | $-95.39M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $106000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $483000.00 | $3.77M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $6.19M | $20.30M | $15.35M | $-3.47M | $-12.02M | $-2.61M | $-3.45M | $31.54M | $-12.39M | $-14.14M | $-14.85M | $-11.91M | $-6.56M | $-4.25M | $-6.33M | $-31.80M | $-72.47M | $-97.22M | $-24.34M | $-90.97M |
| Net income growth (YoY) | — | +228.1% | -24.4% | -122.6% | -246.8% | +78.3% | -31.9% | +1015.4% | -139.3% | -14.2% | -5.0% | +19.8% | +45.0% | +35.3% | -49.2% | -402.1% | -127.9% | -34.1% | +75.0% | -273.7% |
| Profit margin | 11.5% | 30.8% | 24.1% | -16.9% | -71.5% | -22.8% | -31.6% | 76.7% | — | — | — | — | — | — | — | — | 4026222.2% | — | — | — |